IT1096381B - 1,1-diossidi dell'acido penicillanico come inibitori di beta-lattamasi - Google Patents

1,1-diossidi dell'acido penicillanico come inibitori di beta-lattamasi

Info

Publication number
IT1096381B
IT1096381B IT24270/78A IT2427078A IT1096381B IT 1096381 B IT1096381 B IT 1096381B IT 24270/78 A IT24270/78 A IT 24270/78A IT 2427078 A IT2427078 A IT 2427078A IT 1096381 B IT1096381 B IT 1096381B
Authority
IT
Italy
Prior art keywords
dioxides
beta
penicillanic acid
lactamase inhibitors
lactamase
Prior art date
Application number
IT24270/78A
Other languages
English (en)
Italian (it)
Other versions
IT7824270A0 (it
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27122691&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IT1096381(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer filed Critical Pfizer
Publication of IT7824270A0 publication Critical patent/IT7824270A0/it
Application granted granted Critical
Publication of IT1096381B publication Critical patent/IT1096381B/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IT24270/78A 1977-06-07 1978-06-06 1,1-diossidi dell'acido penicillanico come inibitori di beta-lattamasi IT1096381B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80432077A 1977-06-07 1977-06-07
US87938178A 1978-02-21 1978-02-21

Publications (2)

Publication Number Publication Date
IT7824270A0 IT7824270A0 (it) 1978-06-06
IT1096381B true IT1096381B (it) 1985-08-26

Family

ID=27122691

Family Applications (1)

Application Number Title Priority Date Filing Date
IT24270/78A IT1096381B (it) 1977-06-07 1978-06-06 1,1-diossidi dell'acido penicillanico come inibitori di beta-lattamasi

Country Status (35)

Country Link
AR (1) AR224111A1 (fr)
AT (2) AT360649B (fr)
AU (1) AU513636B2 (fr)
BE (1) BE867859A (fr)
BG (2) BG34615A3 (fr)
CH (1) CH634073A5 (fr)
CS (1) CS208472B2 (fr)
DD (2) DD148585A5 (fr)
DE (2) DE2824535C3 (fr)
DK (1) DK155740C (fr)
EG (1) EG13869A (fr)
FI (1) FI66003C (fr)
FR (2) FR2393804A1 (fr)
GB (1) GB2000138B (fr)
GR (1) GR72255B (fr)
HK (1) HK13184A (fr)
HU (1) HU180042B (fr)
IE (1) IE47079B1 (fr)
IL (2) IL54867A (fr)
IN (1) IN149747B (fr)
IT (1) IT1096381B (fr)
KE (1) KE3355A (fr)
LU (1) LU79774A1 (fr)
MY (1) MY8500092A (fr)
NL (2) NL180009C (fr)
NO (2) NO151746C (fr)
NZ (1) NZ187476A (fr)
OA (1) OA05964A (fr)
PH (3) PH26810A (fr)
PL (1) PL114501B1 (fr)
PT (1) PT68146A (fr)
SE (2) SE436206B (fr)
SG (1) SG65383G (fr)
SU (1) SU860706A1 (fr)
YU (1) YU41829B (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU77306A1 (fr) * 1977-05-09 1979-01-18
DE2912511C2 (de) * 1977-06-07 1982-06-24 Pfizer Inc., 10017 New York, N.Y. Pharmazeutische Zusammensetzung, enthaltend Penicillansäure
DK155942C (da) * 1977-12-23 1989-10-23 Pfizer Analogifremgangsmaade til fremstilling af 6-aminopenicillansyre-1,1-dioxid og fysiologisk acceptable syreadditions- og basesalte deraf.
JPS54126735A (en) * 1978-03-24 1979-10-02 Toyama Chem Co Ltd Bactericidal composition for medical use
US4241050A (en) * 1978-09-01 1980-12-23 Pfizer Inc. Penam 1,1-dioxides as beta-lactamase inhibitors
CA1158639A (fr) * 1978-12-11 1983-12-13 Eric M. Gordon Acide 6-bromopenicillanique sulfone
IE49881B1 (en) * 1979-02-13 1986-01-08 Leo Pharm Prod Ltd B-lactam intermediates
SE449103B (sv) * 1979-03-05 1987-04-06 Pfizer Sett att framstella penicillansyra-1,1-dioxid samt estrar derav
US4714761A (en) * 1979-03-05 1987-12-22 Pfizer Inc. 6,6-dihalopenicillanic acid 1,1-dioxides and process
US4420426A (en) 1979-03-05 1983-12-13 Pfizer Inc. 6-Alpha-halopenicillanic acid 1,1-dioxides
GB2045236A (en) * 1979-03-26 1980-10-29 Hoechst Uk Ltd Oxapenem derivatives
US4309347A (en) 1979-05-16 1982-01-05 Pfizer Inc. Penicillanoyloxymethyl penicillanate 1,1,1',1'-tetraoxide
US4244951A (en) * 1979-05-16 1981-01-13 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
IE49768B1 (en) * 1979-05-21 1985-12-11 Leo Pharm Prod Ltd 6beta-halopenicillanic acid derivatives
DE3051044C2 (fr) * 1979-06-19 1989-03-30 Leo Pharmaceutical Products Ltd. A/S (Loevens Kemiske Fabrik Produktionsaktieselskab), Ballerup, Dk
US4256733A (en) * 1979-09-26 1981-03-17 Pfizer Inc. Acetoxymethyl penam compounds as β-lactamase inhibitors
US4432970A (en) * 1979-11-23 1984-02-21 Pfizer Inc. 6-beta-Halopenicillanic acid 1,1-dioxides as beta-lactamase inhibitors
IL61880A (en) * 1980-01-21 1984-11-30 Bristol Myers Co 2beta-chloromethyl-2alpha-methylpenam-3alpha-carboxylic acid sulfone derivatives,their preparation and pharmaceutical compositions containing them
US4432903A (en) * 1980-09-08 1984-02-21 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
US4488994A (en) * 1980-09-08 1984-12-18 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
US4474698A (en) * 1980-12-11 1984-10-02 Pfizer Inc. Process for preparing esters of penicillanic acid sulfone
US4419284A (en) * 1981-03-23 1983-12-06 Pfizer Inc. Preparation of halomethyl esters (and related esters) of penicillanic acid 1,1-dioxide
DE3261759D1 (en) * 1981-07-15 1985-02-14 Kanebo Ltd Novel ester of 1,1-dioxopenicillanic acid, process for production thereof, and use thereof as beta-lactamase inhibitor
PT76526B (en) * 1982-04-19 1986-01-21 Gist Brocades Nv Preparation of 6-alpha-bromo- and/or 6,6-dibromopenicillanic acid 1,1-dioxides
US4502988A (en) * 1983-08-08 1985-03-05 Eli Lilly And Company Oxidation process
EP0139047A1 (fr) * 1983-10-18 1985-05-02 Gist-Brocades N.V. Procédé de préparation de 1,1-dioxyde d'acide 6,6-dibromopénicillanique
US4647457A (en) * 1983-12-16 1987-03-03 Hoffmann-La Roche Inc. Penicillanic acid derivatives
DE3780112T2 (de) * 1986-04-10 1992-12-24 Leo Pharm Prod Ltd Verfahren zur herstellung von penicillansaeure-derivaten.
GB8808701D0 (en) * 1988-04-13 1988-05-18 Erba Carlo Spa Beta-lactam derivatives
CN102977120B (zh) * 2012-12-14 2015-05-27 江西富祥药业股份有限公司 一种舒巴坦匹酯制备及结晶方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3197466A (en) * 1961-10-30 1965-07-27 Smith Kline French Lab Penicillin sulfoxides and process
LU77306A1 (fr) * 1977-05-09 1979-01-18
JPS5439090A (en) * 1977-07-13 1979-03-24 Glaxo Group Ltd Betaalactam compound and its preparation

Also Published As

Publication number Publication date
GB2000138B (en) 1982-03-03
DE2824535B2 (de) 1980-05-14
AU513636B2 (en) 1980-12-11
SE447995B (sv) 1987-01-12
LU79774A1 (fr) 1980-01-22
KE3355A (en) 1983-12-16
NO151746B (no) 1985-02-18
NL930064I1 (nl) 1993-09-01
FR2393804A1 (fr) 1979-01-05
SE8305916D0 (sv) 1983-10-27
ATA411278A (de) 1980-06-15
DD140888A5 (de) 1980-04-02
DE2824535C3 (de) 1981-01-22
AR224111A1 (es) 1981-10-30
HK13184A (en) 1984-02-24
PL114501B1 (en) 1981-02-28
DE2857263B2 (de) 1981-04-23
NO152448B (no) 1985-06-24
IN149747B (fr) 1982-04-03
NO151746C (no) 1985-06-05
BG34615A3 (en) 1983-10-15
FI66003B (fi) 1984-04-30
BG34614A3 (en) 1983-10-15
CH634073A5 (en) 1983-01-14
NL7806126A (nl) 1978-12-11
IT7824270A0 (it) 1978-06-06
NZ187476A (en) 1982-08-17
NO152448C (no) 1985-10-02
GR72255B (fr) 1983-10-06
MY8500092A (en) 1985-12-31
FI781800A (fi) 1978-12-08
DK155740C (da) 1989-10-23
SE436206B (sv) 1984-11-19
CS208472B2 (en) 1981-09-15
OA05964A (fr) 1981-06-30
IE781140L (en) 1978-12-07
DK251478A (da) 1978-12-08
FR2393805A1 (fr) 1979-01-05
IL62168A0 (en) 1981-03-31
FR2393805B1 (fr) 1984-02-24
FI66003C (fi) 1984-08-10
IL54867A0 (en) 1978-08-31
SE7806628L (sv) 1978-12-08
AT360649B (de) 1981-01-26
PH16465A (en) 1983-10-20
PH21116A (en) 1987-07-16
IE47079B1 (en) 1983-12-14
YU117078A (en) 1983-01-21
DK155740B (da) 1989-05-08
SU860706A1 (ru) 1981-08-30
PH26810A (en) 1992-11-05
GB2000138A (en) 1979-01-04
BE867859A (fr) 1978-12-06
AU3683878A (en) 1979-12-06
DD148585A5 (de) 1981-06-03
HU180042B (en) 1983-01-28
NL930064I2 (nl) 1994-04-18
NO823126L (no) 1978-12-08
DE2857263C3 (de) 1981-12-17
SE8305916L (sv) 1983-10-27
EG13869A (en) 1983-03-31
YU41829B (en) 1988-02-29
FR2393804B1 (fr) 1980-11-07
PL207396A1 (pl) 1979-06-04
ATA128580A (de) 1981-02-15
NL180009C (nl) 1986-12-16
PT68146A (en) 1978-07-01
NO781970L (no) 1978-12-08
IL54867A (en) 1981-11-30
DE2824535A1 (de) 1978-12-14
AT364084B (de) 1981-09-25
SG65383G (en) 1985-03-29

Similar Documents

Publication Publication Date Title
IT1096381B (it) 1,1-diossidi dell'acido penicillanico come inibitori di beta-lattamasi
IT1083653B (it) Procedimento per la produzione di derivati dell acido penicillanico
IT7824178A0 (it) Procedimento di sintesi dell'acido ascorbico.
IT7823200A0 (it) Processo e reagente per la determinazione dell'acido ascorbico.
IT7926924A0 (it) Procedimento di fabbricazione dell'acido para-idrossimandelico racemico.
IT1105937B (it) Processo di clorurazione dell ilmenite
DK166353C (da) Penicillansyre-1,1-dioxid-derivater
IT1087977B (it) Purificazione dell'acido fosforico.
BE869194A (fr) Production de benzamides heterocycliques
IT8025223A0 (it) Procedimento per la produzione di derivati dell'acido penicillanico.
PL204551A1 (pl) Sposob wytwarzania nowych pochodnych kwasu benzoheterocykloglioksalowego
IT1156871B (it) Procedimento per la produzione di ossime derivate dell'acido 7-amminotiazolilacetammido-cefalororanico
IT1089147B (it) Purificazione dell'acido fosforico
IT7821941A0 (it) Composti dell'acido 4(2-tienilmetilamino)benzoico.
IT1096951B (it) Procedimento per la produzione di acido clorosolfonico
IT8026521A0 (it) Derivati dell'acido carbotioico di mercaptoacilamminoacidi.
IT1089414B (it) Processo per la preparazione dell'acido 3-idrossi-3-metilglutarco
IT7820725A0 (it) Esteri dell'acido ciclopropancarbossilico.
IT1094526B (it) Metodo di produzione dell'amido
IT7820337A0 (it) Derivati dell'acido fenilpentanoico.
IT1157741B (it) Procedimento per la produzione di acido 2-acetammido-cinnamico
IT1106945B (it) Procedimento per la produzione di cloruro di acido pentaclorovinil-acetico
IT1165251B (it) Metodo di furificazione dell'acido chenodesossicolico
DE3263337D1 (de) Salts of penicillanic acid 1,1-dioxide
DK399582A (da) Penicillansyre-1-oxider

Legal Events

Date Code Title Description
ITCP Complementary protection certificate

Free format text: CCP 122

MEDD Supplementary protection certificate for pharmaceutical products: granted

Free format text: CCP 122, 19920417; PFIZER INC.

TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970417